What is Amphastar Pharmaceuticals's PP&E (net)?

Amphastar Pharmaceuticals (AMPH) reported PP&E (net) of $307.23M in Q1 2026.

How has Amphastar Pharmaceuticals's PP&E (net) changed year-over-year?

Amphastar Pharmaceuticals's PP&E (net) decreased by 0.1% year-over-year, from $307.6M to $307.23M.

What is the long-term trend for Amphastar Pharmaceuticals's PP&E (net)?

Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's PP&E (net) has grown at a 3.6% compound annual growth rate (CAGR), from $260.06M to $310.57M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Amphastar Pharmaceuticals AMPH PP&E (Net)

PP&E (Net) at other companies

PfizerPFE

$19.4B+5.8%

ViatrisVTRS

$2.53B-4.1%

Opko HealthOPK

$72.59M+2.0%

AptarGroupATR

$1.66B+11.5%

ARS Pharmaceuticals, Inc.SPRY

$2.29M+113%

Halozyme TherapeuticsHALO

——

Segments

By geography

See full

US$235.03M+12.8%

CN$108.56M-1.7%

FR$35.32M+1.0%

Other financials

Income statement

See full

Revenue$171.2M+0.4%

Gross profit$70.3M-17.5%

Operating income$13.6M-63.5%

Net income$6.4M-74.6%

EPS (diluted)$0.14-72.5%

Balance sheet

See full

Cash & equivalents$170.9M-6.5%

Total debt$686.6M+5.2%

Total equity$445.5M—

Total assets$1.6B+1.3%

Cash flow

See full

Operating cash flow$47.8M+36.4%

CapEx$9.5M-11.1%

Free cash flow$38.3M+57.2%

Valuation

See full

Market cap$926.83M-19.9%

Enterprise value$1.44B-11.3%

P/E11.7×+3.5×

P/S1.3×-0.3×

Profitability

See full

Gross margin47.3%-3.2pp

Operating margin16.2%-10.4pp

Net margin11%-8.4pp

FCF margin18.8%-1.8pp

Returns & leverage

See full

Return on equity14.7%—

Debt / equity0.2×—

Current ratio3.9×+0.9×

Where this comes from

Reported directly by Amphastar Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amphastar Pharmaceuticals's PP&E (net)?: Amphastar Pharmaceuticals (AMPH) reported PP&E (net) of $307.23M in Q1 2026.
How has Amphastar Pharmaceuticals's PP&E (net) changed year-over-year?: Amphastar Pharmaceuticals's PP&E (net) decreased by 0.1% year-over-year, from $307.6M to $307.23M.
What is the long-term trend for Amphastar Pharmaceuticals's PP&E (net)?: Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's PP&E (net) has grown at a 3.6% compound annual growth rate (CAGR), from $260.06M to $310.57M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.